To ensure the opening of upcoming Homi Bhabha Cancer Hospital and Research Centre in Medicity at New Chandigarh (Mohali), Punjab Government has started a weekly review of the progress of the prestigious project. At the same time, the state Chief Secretary Vini Mahajan has asked all the stakeholders to ensure that the ultra-modern cancer tertiary care facility is made operational by November.
The Chief Secretary was jointly reviewing progress of the project with Tata Memorial Centre, Mumbai, Director Dr RA Badwe, Principal Secretary Health and Medical Education Alok Shekhar and Principal Secretary PWD Vivek Pratap, here. Mahajan had visited the project site to review the progress and assess the current status of the ambitious health institution, coming up in the vicinity of Chandigarh PGIMER, the previous week.
It was decided at the meeting that all pending works in C-wing shall be completed before September 15 in order to enable the installation of radiology equipment at the earliest.
To make functional essential facilities like patient care areas and installation of machines, Mahajan said that the installation of the Linac machine in D-wing should begin from September 3. She also enquired about the status of various hospital and office furniture.
Expressing satisfaction over the progress, Mahajan asked the entire project executing team to achieve and finish targets as per the schedule as the Chief Minister Captain Amarinder Singh has also desired to make available the 300-bed state-of-the-art cancer hospital to the people at the earliest, which would provide tertiary care medical services to the entire northern region.
MANY SERVICES TO BE AVAILABLE FROM NOV
The Homi Bhabha Cancer Hospital and Research Centre, New Chandigarh, will start radiotherapy, radiology, CT scan, MRI, ultrasound, x-ray, mammography, medical oncology, chemotherapy, day-care ward, pathology, laboratory facilities and minor OT, besides initiating OPD services such as surgical oncology, medical oncology, radiation oncology, palliative care preventive oncology for the public from November onwards.